 Shares of Galera Therapeutics Inc NASDAQ: GRTX tanked 73 on Tuesday after the company said its Avasopasem trial did not meet the primary endpoint. Avasopasem does not significantly reduce the incidence of SOM Galera was running a Phase III trial for Avasopasem Manganese in patients with locally advanced head and neck cancer HNC in hopes ... The post Galera Therapeutics plummeted 73 on Tuesday: explore why appeared first on Invezz. 